http://www.fool.com/News/mft/2006/mft06041920.htm?ref=btpGilead's Got Cash Up to the GillsBy John Bluis April 19, 2006 Gilead Sciences (Nasdaq: GILD) celebrated its ninth straight quarter of beating analyst estimates, trouncing its year-ago results even after the newly added expensing of stock-based compensation costs. Diluted EPS rose 61.7% to $0.55, compared to the $0.34 in the first quarter of 2005. I also calculated -- for your convenience -- a 73.5% increase in diluted EPS without stock-based compensation costs of $0.04 per diluted share.....
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar